PCV25- CHD RISK FACTORS AND THERAPY DURATION OF HMG-COA REDUCTASE INHIBITORS (STATINS) IN A MEDICAID POPULATION
Sep 1, 2001, 00:00
10.1046/j.1524-4733.2001.40202-99.x
https://www.valueinhealthjournal.com/article/S1098-3015(11)71258-X/fulltext
Title :
PCV25- CHD RISK FACTORS AND THERAPY DURATION OF HMG-COA REDUCTASE INHIBITORS (STATINS) IN A MEDICAID POPULATION
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)71258-X&doi=10.1046/j.1524-4733.2001.40202-99.x
First page :
Section Title :
Open access? :
No
Section Order :
150